PALbociclib CoLlaborative Adjuvant Study
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Palbociclib|DRUG: Standard Adjuvant Endocrine Therapy
Sponsor: Alliance Foundation Trials, LLC.
Collaborators: Austrian Breast & Colorectal Cancer Study Group|NSABP Foundation Inc|PrECOG, LLC.|Breast International Group|Pfizer